Effects of Memantine on Cognitive Flexibility in a Valproic Acid Rat Model of Autism

• Published in: QJM : An International Journal of Medicine Vol. 117; no. Supplement_1
• Main Authors: Zohny, Sohir M, Habib, Mohamed Z, Mohamad, Magda I, Elayat, Wael M, Elhossiny, Reham M, Abd El-salam, Mohamed F, Hassan, Ghada A M, Aboul-Fotouh, Sawsan
• Format: Journal Article
• Language: English
• Published: 03-07-2024
• ISSN: 1460-2725; 1460-2393
• DOI: 10.1093/qjmed/hcae070.527

Abstract Autistic children frequently struggle with cognitive flexibility. The potential molecular mechanism underlying cognitive inflexibility remains unclear. Decreased level of brain-derived neurotrophic factor (BDNF), which plays a vital role in neural development and synaptic plasticity may have a role. This study aimed to investigate the effects of memantine on (BDNF) expression in hippocampus of prenatal VPA exposed rats, and its consequent effects on cognitive flexibility. Pregnant female rats received a single intraperitoneal injection of VPA (600 mg/kg) on gestational day 12.5 to induce autistic-like behaviors in their offspring. Afterwards, the 23-day-old male Wistar rat pups received daily intraperitoneal injections of memantine (20 mg/kg) for 4 weeks. The prenatal VPA-exposed rats exhibited reduced cognitive flexibility in the attentional set- shifting task (ASST) reflecting ASD-associated cognitive flexibility deficits, a common ASD- associated problem with accompanied reduction in hippocampal BDNF. The defective performance in ASST was more prominent in the reversal stages. Memantine associated increased hippocampal BDNF could alleviate cognitive inflexibility in ASD. This study draws attention to the potential favorable effect of memantine on cognitive performance in autistic subjects.